123 research outputs found
Reduced Routley-Meyer semantics for the logics characterized by natural implicative expansions of Kleene's strong 3-valued matrix
15 p.The aim of this paper is to provide a reduced Routley-Meyer semantics for the logics characterized by all natural implicative expansions of Kleene’s strong 3-valued matrix (with two designated values, as well as with only one) susceptible to be interpreted in Routley-Meyer semantics.S
Selecting the Class of All 3-Valued Implicative Expansions of Kleene's Strong Logic Containing Routley and Meyer's Logic B
We define all implicative expansions of Kleene's strong 3-valued matrix (with both only one and two designated values) verifying Routley and Meyer's basic logic B. Then, the logics determined by each one of these implicative expansions are axiomatized by using a Belnap-Dunn "two-valued" semantics. This semantics is "overdetermined" in the case of two designated values, and "underdetermined" when there is only one.SIMinisterio de Economía, Industria y Competitivida
Partiality and its dual in natural implicative expansions of Kleene’s strong 3-valued matrix with only one designated value
26 p.Equivalent overdetermined and underdetermined bivalent Belnap–Dunn type semantics for the logics determined by all natural implicative expansions of Kleene’s strong 3-valued matrix with only one designated value are provided.S
Relational Semantics for the Paraconsistent and Paracomplete 4-valued Logic PŁ4
[EN] The paraconsistent and paracomplete 4-valued logic PŁ4 is originally interpreted with a two-valued Belnap-Dunn semantics. In the present paper, PŁ4 is endowed with both a ternary Routley-Meyer semantics and a binary Routley semantics together with their respective restriction to the 2 set-up cases.SIMinisterio de Ciencia e Innovación (MCIN/AEI/ 10.13039/501100011033
Belnap-Dunn semantics for natural implicative expansions of Kleene's strong three-valued matrix II. Only one designated value
21 p.This paper is a sequel to ‘Belnap-Dunn semantics for natural implicative expansions of Kleene's strong three-valued matrix with two designated values’, where a ‘bivalent’ Belnap-Dunn semantics is provided for all the expansions referred to in its title. The aim of the present paper is to carry out a parallel investigation for all natural implicative expansions of Kleene's strong 3-valued matrix now with only one designated value.S
Aberrant Epstein-Barr virus antibody patterns and chronic lymphocytic leukemia in a Spanish multicentric case-control study
BACKGROUND:
Epstein-Barr virus (EBV)-related malignancies harbour distinct serological responses to EBV antigens. We hypothesized that EBV serological patterns can be useful to identify different stages of chronic lymphocytic leukemia.
METHODS:
Information on 150 cases with chronic lymphocytic leukemia and 157 frequency-matched (by age, sex and region) population-based controls from a Spanish multicentre case-control study was obtained. EBV immunoglobulin G serostatus was evaluated through a peptide-based ELISA and further by immunoblot analysis to EBV early antigens (EA), nuclear antigen (EBNA1), VCA-p18, VCA-p40 and Zebra. Two independent individuals categorized the serological patterns of the western blot analysis. Patients with very high response and diversity in EBV-specific polypeptides, in particular with clear responses to EA-associated proteins, were categorized as having an abnormal reactive pattern (ab_EBV). Adjusted odds ratios (OR) and 95% confidence interval (CI) were estimated using logistic regression models.
RESULTS:
Almost all subjects were EBV-IgG positive (>95% of cases and controls) whereas ab_EBV patterns were detected in 23% of cases (N = 34) and 11% of controls (N = 17; OR: 2.44, 95% CI, 1.29 to 4.62; P = 0.006), particularly in intermediate/high risk patients. Although based on small numbers, the association was modified by smoking with a gradual reduction of ab_EBV-related OR for all Rai stages from never smokers to current smokers.
CONCLUSIONS:
Highly distinct EBV antibody diversity patterns revealed by immunoblot analysis were detected in cases compared to controls, detectable at very early stages of the disease and particularly among non smokers. This study provides further evidence of an abnormal immunological response against EBV in patients with chronic lymphocytic leukemia
Aberrant Epstein-Barr virus antibody patterns and chronic lymphocytic leukemia in a Spanish multicentric case-control study
Background: Epstein-Barr virus (EBV)-related malignancies harbour distinct serological responses to EBV antigens. We hypothesized that EBV serological patterns can be useful to identify different stages of chronic lymphocytic leukemia. Methods: Information on 150 cases with chronic lymphocytic leukemia and 157 frequency-matched (by age, sex and region) population-based controls from a Spanish multicentre case-control study was obtained. EBV immunoglobulin G serostatus was evaluated through a peptide-based ELISA and further by immunoblot analysis to EBV early antigens (EA), nuclear antigen (EBNA1), VCA-p18, VCA-p40 and Zebra. Two independent individuals categorized the serological patterns of the western blot analysis. Patients with very high response and diversity in EBV-specific polypeptides, in particular with clear responses to EA-associated proteins, were categorized as having an abnormal reactive pattern (ab_EBV). Adjusted odds ratios (OR) and 95% confidence interval (CI) were estimated using logistic regression models. Results: Almost all subjects were EBV-IgG positive (>95% of cases and controls) whereas ab_EBV patterns were detected in 23% of cases (N = 34) and 11% of controls (N = 17; OR: 2.44, 95% CI, 1.29 to 4.62; P = 0.006), particularly in intermediate/high risk patients. Although based on small numbers, the association was modified by smoking with a gradual reduction of ab_EBV-related OR for all Rai stages from never smokers to current smokers. Conclusions: Highly distinct EBV antibody diversity patterns revealed by immunoblot analysis were detected in cases compared to controls, detectable at very early stages of the disease and particularly among non smokers. This study provides further evidence of an abnormal immunological response against EBV in patients with chronic lymphocytic leukemia
Adherence to the Western, Prudent, and Mediterranean dietary patterns and chronic lymphocytic leukemia in the MCC-Spain study.
Diet is a modifiable risk factor for several neoplasms but evidence for chronic lymphocytic leukemia (CLL) is sparse. Previous studies examining the association between single-food items and CLL risk have yielded mixed results, while few studies have been conducted on overall diet, reporting inconclusive findings. This study aimed to evaluate the association between adherence to three dietary patterns and CLL in the multicase-control study (MCC-Spain) study. Anthropometric, sociodemographic, medical and dietary information was collected for 369 CLL cases and 1605 controls. Three validated dietary patterns, Western, Prudent and Mediterranean, were reconstructed in the MCC-Spain data. The association between adherence to each dietary pattern and CLL was assessed, overall and by Rai stage, using mixed logistic regression models adjusted for potential confounders. High adherence to a Western dietary pattern (i.e. high intake of high-fat dairy products, processed meat, refined grains, sweets, caloric drinks, and convenience food) was associated with CLL [ORQ4 vs. Q1=1.63 (95%CI 1.11; 2.39); P-trend=0.02; OR 1-SD increase=1.19 (95%CI: 1.03; 1.37)], independently of Rai stages. No differences in the association were observed according to sex, Body Mass Index, energy intake, tobacco, physical activity, working on a farm, or family history of hematologic malignancies. No associations were observed for Mediterranean and Prudent dietary patterns and CLL. This study provides the first evidence for an association between a Western dietary pattern and CLL, suggesting that a proportion of CLL cases could be prevented by modifying dietary habits. Further research, especially with a prospective design, is warranted to confirm these findings
- …